Siga Technologies (SIGA) Share-based Compensation (2010 - 2025)
Siga Technologies (SIGA) posted Share-based Compensation of $433763.0 for Q3 2025, up 361.0% on a QoQ basis from -$166193.0 in Q2 2025, and down 46.7% year-over-year from $813774.0 in Q3 2024.
Siga Technologies (SIGA) Share-based Compensation (2010 - 2025) Analysis & Trends
Siga Technologies' Share-based Compensation history runs 16 years deep, the most recent figure standing at $433763.0 for Q3 2025.
- Quarterly Share-based Compensation fell 46.7% year-over-year to $433763.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$2.0 million (down 160.66% YoY) and the FY2024 annual result came in at $1.4 million, down 31.79% from the prior year.
- Share-based Compensation was $433763.0 for Q3 2025 at Siga Technologies, up from -$166193.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.8 million in Q4 2022 and bottomed at -$2.5 million in Q4 2024.
- A 5-year average of $332363.1 and a median of $446793.0 in 2023 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 2659.93% — and 2024, when it sank 631.73%.
- Siga Technologies' Share-based Compensation stood at $1.1 million in 2021, then jumped by 58.01% to $1.8 million in 2022, then tumbled by 74.01% to $462469.0 in 2023, then sank by 631.73% to -$2.5 million in 2024, then soared by 117.64% to $433763.0 in 2025.
- Business Quant data shows SIGA's Share-based Compensation at $433763.0 in Q3 2025, -$166193.0 in Q2 2025, and $166193.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 433,763.00 |
| Sep 30, 2025 | 433,763.00 |
| Jun 30, 2025 | -166,193.00 |
| Jun 30, 2025 | -166,193.00 |
| Mar 31, 2025 | 166,193.00 |
| Mar 31, 2025 | 166,193.00 |
| Dec 31, 2024 | -2.46 Mn |
| Dec 31, 2024 | -2.46 Mn |
| Sep 30, 2024 | 813,774.00 |
| Sep 30, 2024 | 813,774.00 |
| Jun 30, 2024 | 932,287.00 |
| Jun 30, 2024 | 932,287.00 |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 462,469.00 |
| Dec 31, 2023 | 462,469.00 |
| Sep 30, 2023 | 459,823.00 |
| Sep 30, 2023 | 459,823.00 |
| Jun 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.13 Mn |